measurement have been questionable. For example, previous studies reported that some indicators commonly used for calcium imaging, e.g., Calcium Green-1 and fura-2, are responsive to zinc with an extremely high affinity, and that specific zinc chelators reduced the intensity of calcium indicators (4) (5) (6) (7) . These findings suggest that some of the biological effects previously assumed to be mediated by -2-Ca 2+ may be mediated, at least partially, by zinc ions. Like calcium, recent studies have demonstrated that zinc ions play an important role in neuronal injuries associated with various neurological conditions (8, 9) . The exact pathways mediating intracellular zinc accumulations and toxicity are, however, not clear. Zinc is one of the most crucial trace metals in the cells. For example, zinc is required for the function of a broad range of enzymes involved in transcription, protein synthesis, and signal transductions (10). Although there is low level of free zinc in the cells, most of zinc ions are bound to intracellular proteins (11) . The mechanisms that affect the free zinc concentration are, therefore, pivotal for maintaining the normal brain function. While the extracellular fluid may contain up to several micromolar of zinc, intracellular zinc concentration ([Zn 2+ ] i ) is generally maintained at 10 -9~1 0 -10 M (10, 12, 13) . This steep gradient across the cell membrane is maintained primarily by zinc extrusion systems such as zinc transporters (ZnTs). At least 10 members of ZnTs, with different tissue distribution, have been identified in the ZnTs family. They promote the efflux of intracellular zinc into extracellular space or uptake of zinc into vesicles (14, 15) . In contrast to ZnTs, Zrt-and Irt-like proteins (ZIPs) are known to transport zinc into the cells (14, 15) . In addition, some calcium channels, e.g. voltage-dependent calcium channels (VDCCs), N-methyl-D-aspartate (NMDA) receptors, and amino-3-hydroxy-5-methyl-4-isoxazol propionate (AMPA)/kinate receptors have been reported to be zinc permeable (16, 17) . The activities of these channels thus affect the intracellular zinc homeostasis and toxicity. Unfortunately, clinical trials using the antagonists of these channels failed to provide a satisfactory neuroprotection (2, 3) .
Transient receptor potential melastatin 7 (TRPM7) is a member of the large TRP channel superfamily expressed in almost every tissue and cell type (18) (19) (20) . Increasing evidence suggests that activation of TRPM7 channels contributes to various physiological and pathophysiological processes (21) (22) (23) . Notably, we demonstrated that activation of TRPM7 channels by oxygen free radicals plays a critical role in hypoxia-induced, glutamate-independent, neuronal injury (24) . In addition to well-established Ca 2+ permeability, TRPM7 is, at present, the only known zinc permeable channel among the TRP family of ion channels (18, 25) . It is reported that the zinc permeability for TRPM7 channels is 4-fold higher than Ca 2+ (25) . Despite these facts, it has not been established whether TRPM7 channels play a role in intracellular zinc dynamics at physiological/pathological relevant concentrations, and more importantly, in zinc-mediated neurotoxicity. Using a combination of fluorescent zinc imaging, metal response element-based reporter gene assay, cell injury analysis, and small interfering RNA techniques, we show strong evidence suggesting that TRPM7 channels represent a novel pathway for intracellular zinc accumulation and zinc mediated neurotoxicity.
Experimental Procedures
Cell culture -Mouse cortical neurons were cultured as described previously (26) . The protocol for the use of mice for neuronal cultures was reviewed and approved by the -3- Human embryonic kidney (HEK293) cells, with inducible expression of human TRPM7 channels (HEK:TRPM7 cells), were cultured in minimal essential medium supplemented with 10% fetal bovine serum and antibiotics (19) . For the induction of TRPM7, the cells were treated with 1 Pg/ml tetracycline, as described in our previous studies (22) .
Immunoblotting -Immunoblotting was performed as described previously (27) . Cells cultured in 35 mm dishes or 6-well plates were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% Triton X-100, and protease inhibitors (Roche Diagnostics)). After centrifugation at 12,000 u g at 4ÛC for 30 min, the lysates were collected. The aliquots were then mixed with Laemmli sample buffer and incubated at 37ÛC for 1 h. The samples were resolved by 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by electrotransfer to polyvinylidene difluoride membranes. For visualization, blots were probed with antibodies against TRPM7 (1:250; Abgent) or E-actin (1:2000; Abcam), and detected using horseradish peroxidase-conjugated secondary antibodies (1:1000; Cell Signaling) and an ECL kit (GE Healthcare). The intensity of the protein band was densitometrically quantified.
Plasmid construction and transfection -
The plasmid containing short hairpin RNA (shRNA) for silencing human TRPM7 was described previously (22) .
To construct the plasmid for silencing mouse TRPM7, two oligonucleotides were annealed and inserted into pSilencer 1.0-U6 (Ambion) according to manufacturer's instruction. The target sequence for TRPM7 corresponded to coding region 5152-5172 (GenBank Accession Number NM021450 (28) . A fragment cut with BamHI was excised and inserted into BamHI site of pCAGGS-eGFP (kindly provided by Dr. J. Miyazaki; Division of Stem Cell Regulation Research, Osaka University Medical School, Osaka, Japan) to express both enhanced green fluorescence protein (eGFP) and shRNA (TRPM7-shRNA/eGFP) (29). For the negative control, a fragment cut with BamHI from pSilencer 1.0-U6 was inserted into pCAGGS-eGFP (control/eGFP).
For transfection, Fugene HD (Roche Diagnostics) and NeuroFect (Genlantis) were used for HEK:TRPM7 cells, and for cortical neurons (between day 8-11 in vitro) in accordance with the -4-manufacturer's instructions. The transfection efficiencies, as determined by eGFP-positive cells, were 2-5% for cultured mouse cortical neurons.
Lactate dehydrogenase (LDH) assay -LDH measurement was performed as described in our previous studies (30, 31) . Cells grown on 24-well plates were first washed with PBS. 50 Pl of the culture medium was taken from each well and placed into a 96-well plate for background LDH measurement. Cells were then treated with zinc containing medium for 1 h or 2 h, followed by wash and incubation in normal culture medium for 23 h or 22 h, respectively. 50 Pl of the medium was transferred from each well to 96-well plates for the measurement of injury-mediated LDH release. For the measurement of maximal releasable LDH, cells were incubated with Triton X-100 (final concentration 0.5%) for 30 min at the end of each experiment. 50 Pl of assay reagent from the cytotoxicity detection kit (Roche Diagnostics) was added to each sample according to the manufacturer's instruction. 30 min later, the absorbance at 492 nm and 620 nm was examined by spectrometer (SpectraMax Plus, Molecular devices). The values of the absorbance at 492 nm were subtracted by those at 620 nm to yield the value of LDH release.
Reporter gene assays -Cells grown on 24-well plates were transfected with p(MREa) 6 -Luc (kindly provided by Dr. C. Seguin; Centre de Recherche en Cancerologie de l'Universite Laval) together with pRL-TK (Promega) to measure the transfection efficiency (32) . Expression plasmids were transfected in the following amounts per well: 0.3 Pg p(MREa) 6 -Luc and 0.1 Pg pLR-TK for HEK:TRPM7 cells; 0.8 Pg shRNA-cotaining pCAGGS-eGFP, 0.9 Pg p(MREa) 6 -Luc, and 0.3 Pg pLR-TK for cortical neurons. Luciferase assays were performed using the Dual-Luciferase Reporter System (Promega) with a microplate luminometer (Veritas TM , Turner Biosystems), in which relative firefly luciferase activity was calculated by normalizing the transfection efficiency according to the activity of renilla luciferase. Relative firefly luciferase activity detected in the cell lysates was presented (33) .
Zinc imaging -The intracellular zinc level of HEK:TRPM7 cells or mouse cortical neurons was imaged using a zinc-sensitive fluorescent dye, FluoZin-3 (Invitrogen). Cells were incubated with 5 μM FluoZin-3-AM in the standard extracellular fluid (ECF) for 30 min at 37ÛC, followed by deesterification of the dye for another 30 min at room temperature (22-25ÛC). The coverslips containing dye-loaded cells were held in a recording chamber placed on the stage of an inverted microscope (Eclipse TE2000-U; Nikon), and superfused with standard ECF at room temperature for at least 10 minutes prior to experiments. FluoZin-3 was excited at a wavelength of 490 nm, and emitted light was filtered with a 500-550 nm band pass filter. Zinc fluorescence was detected with a 40 u objective lens (Super Fluor 40 u, numerical aperture = 0.90; Nikon) and a CCD camera (CoolSNAP ES2; Photometrics), using the Imaging Workbench Software (INDEC BioSystems). Fluorescence intensities ('F) were normalized to the resting values (F, average of five-data points recorded immediately before the change of solutions).
-5-Solutions -For electrophysiology recording and zinc imaging, cells were superfused with a standard ECF containing (in mM) 140 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 33 glucose, 20 HEPES (pH 7.4, adjusted with NaOH, and 320-335 mOsm with sucrose). For cortical neurons, MK-801 (10 PM; Sigma-Aldrich), 6-cyano-7-nitroquinoxaline-2,3-dione (20 PM; Sigma-Aldrich) and nimodipine (5 PM; Sigma-Aldrich) were included in the extracellular solutions to block potential zinc entry through NMDA and AMPA/kinate receptors, and VDCCs.
Oxygen-glucose deprivation (OGD) -OGD was performed as described in our previous studies (30) . The cultured cells were treated with glucose-free ECF containing (in mM) 140 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 33 N-methyl-D-glucamine (or N-methyl-D-glucammonium at physiological pH) and 20 HEPES (pH 7.4, 320-335 mOsm), and then transferred to an anaerobic chamber containing 5% CO 2 and 95% N 2 atmosphere for 1 h. Cells were then washed with PBS and placed in normal cell culture incubator. All OGD experiments were carried out at 37ÛC.
Propidium iodide (PI) staining and analysis of cell injury -Cortical neurons
were cultured on etched coverslips (Bellco Biotechnology) for the monitoring of same cells before and after treatments. Three days after transfection, cells were treated with the indicated conditions for 1 h and then incubated in the normal culture medium for 23 h. PI was added to the culture medium to a final concentration of 5 Pg/ml. Images of the eGFP-positive cells were taken with the same fluorescent microscope used for zinc imaging. PI-positive cells were regarded as injured cells. PI was excited at a wavelength of 540 nm, and emitted light was filtered with a 550-660 nm band pass filter. 6-20 cells were evaluated in each culture, and 3-5 independent cultures were included for each group.
Electrophysiology
Whole-cell patch-clamp recordings were performed as described previously (22, 34) . 3-4 days after transfection, cells were set on the stage of the microscope and continuously superfused with ECF at room temperature. Patch electrodes were fabricated from borosilicate capillary tubings of 1.5 mm diameter (WPI) using a Narishige PP-83 vertical puller (Narishige). The electrode resistance ranged from 3 to 4 M when filled with the intracellular solution. Membrane currents were recorded using an Axopatch 200B amplifier. Data were filtered at 2 kHz and digitized at 5 kHz by using a Digidata 1322A data-acquisition system (Molecular Devices). Pipettes were filled with a solution containing (in mM) 140 CsF, 11 EGTA, 5 tetraethyl-ammonium chloride, and 10 HEPES (pH 7.3, adjusted with CsOH). A multibarrel perfusion system (SF-77B, Warner Instrument) was employed for rapid exchange of solutions.
Statistical analysis -Data were expressed as means ± S.E. Groups were compared using one-way ANOVA followed by Dunnett's test or unpaired Student's t-test as appropriate. p < 0.05 was regarded as statistically significant. *p < 0.05, **p < 0.01.
RESULTS

Activation of TRPM7 channels enhances zinc toxicity in mouse cortical
-6-neuron. Functional TRPM7 channels are expressed in neuronal cells where they play important roles in both physiological and pathological conditions (24, 35) . Also, zinc ions have been reported to permeate through TRPM7 channels in heterologous expression systems (25) . However, whether TRPM7 channels play a role in neuronal zinc dynamics and zinc-mediated neurotoxicity has never been explored. Therefore, we first examined whether promoting the activation of these channels affects zinc-induced injury of cultured mouse cortical neurons. In all experiments, the blockers for NMDA receptors, AMPA/kinate receptors, and VDCCs were included in the extracellular solutions to eliminate the potential zinc entry through these pathways (see Experimental Procedures). When 30 PM zinc was added to the extracellular solution to mimic the condition of brain ischemia (12, 36, 37) , mouse cortical neurons showed a slight increase of cell injury as demonstrated by morphological changes (Fig. 1A) and increased LDH release measured at 24 h after zinc incubation (Fig. 1B) . This zinc-induced cell injury was, however, dramatically exacerbated by Ca 2+ /Mg 2+ removal ( Fig. 1A and B) , a condition known to activate TRPM7 channels (22, 24, 28) . These results suggest that activation of TRPM7 channels promotes the zinc toxicity in native neurons. Consistent with an involvement of TRPM7 channels, addition of Gd 3+ and 2-aminoethoxydiphenyl borate (2-APB), non-specific inhibitors of TRPM7 channels (22, 24, 25, 28, 34) , both attenuated zinc-induced neuronal injury (Fig. 1C) .
Activation of TRPM7 channels increases [Zn
2+
] i in neurons. We next examined whether altering the function of TRPM7 channels affects intracellular zinc accumulation in cultured mouse cortical neurons using a zinc indicator FluoZin-3 (38) . As shown in Fig. 2A and B, application of 30 PM zinc in normal ECF slightly increased FluoZin-3 fluorescence intensity in cortical neurons ( Fig. 2A and B Fig. 1A ). Addition of (2-pyridylmethyl) ethylenediamine (TPEN), a high affinity zinc chelator (31) , completely eliminated the increase of FluoZin-3 fluorescence intensity (Supplemental Fig. 2A ). Together, these data suggest that activation of TRPM7 channels can cause increases of [Zn 2+ ] i in mouse cortical neurons.
Overexpression of TRPM7 channels enhances the zinc toxicity in HEK293 cells.
To provide further evidence supporting the contribution of TRPM7 channels to zinc toxicity, we investigated if changing the expression level of TRPM7 channels influences the zinc-mediated cell injury. We used HEK293 cells with inducible expression of TRPM7 channels (19, 22) . In the absence of induced expression of TRPM7 channels (TRPM7(-) cells), incubation of HEK293 cells with 30 μM zinc for 1 h did not induce increase of LDH release, although incubation with higher concentrations of zinc (100-1000 PM) did induce significant increase of LDH release (Fig. 3A) . However, when overexpression -7-of TRPM7 channel was induced by adding tetracycline (TRPM7(+) cells), incubation of HEK293 cells with zinc induced greater increase of LDH release, suggesting that increased expression of TRPM7 channels exacerbates zinc-induced cell damage.
To confirm that the enhancement of zinc-mediated cell injury was indeed due to TRPM7 overexpression, RNA interference was employed to silence the TRPM7 gene expression. Transfection of TRPM7(+) cells with TRPM7-shRNA reduced TRPM7 protein level by ~50% at 48 h post induction, as compared with cells transfected with a mock vector (Fig. 3B) . This reduction in the protein level of TRPM7 was accompanied by a significant attenuation of zinc-induced LDH release (Fig. 3C ), further supporting a role of TRPM7 channels in zinc-induced injury of HEK293 cells. In this experiment, a high concentration of zinc (1000 μM) was used to induce more cell death, which allows for easier detection of the reduction of cell injury by TRPM7-shRNA treatment. (32, 39) . Thus, by measuring the MRE-dependent reporter activity, intracellular zinc levels can be indirectly evaluated (32, 39) . As shown in Fig. 4C , TRPM7(+) cells were dramatically more responsive to zinc application than TRPM7(-) cells, suggesting higher intracellular zinc level in TRPM7(+) cells. In addition to zinc application, TRPM7(+) cells also showed a higher baseline reporter activity (Fig. 4C ), consistent with a higher basal level of [Zn 2+ ] i in these cells. Zinc induced increase of reporter activity was also blocked by the addition of TPEN (Supplemental Fig. 3 ). (Fig. 5B) . These results strongly suggest that TRPM7 channels play an important role in zinc accumulation in mouse cortical neurons.
TRPM7 overexpression increases
Zinc accumulation in neurons was
Zinc induced neuronal injury was attenuated
by TRPM7-shRNA. To determine whether TRPM7 channels are involved in zinc-mediated neurotoxicity, the degree of zinc-induced injury of cultured mouse cortical neurons grown on etched coverslips was compared between TRPM7-shRNA/eGFP transfected and control/eGFP transfected cells. eGFP-positive neurons were recorded before and 24 h after a 1 h incubation with 30 μM zinc. As shown in Fig. 6A and B, incubation of control/eGFP neurons with 30 μM zinc induced ~50% of cell death. However, the same treatment induced less than 30% injury of neurons transfected with TRPM7-shRNA/eGFP ( Fig. 6A and  B) . Similar to control/eGFP transfected cells, 1 h incubation with 30 μM zinc induced ~50% of cell death in eGFP-negative cells. Thus, TRPM7 channels play an important role in zinc-induced injury of mouse cortical neurons.
TRPM7 channels mediate zinc toxicity under OGD condition. Finally, we determined whether TRPM7-mediated zinc toxicity is also involved in the condition of OGD, an in vitro model of ischemia. Consistent with our previous studies (24), 1 h ODG, in the presence of the blockers of glutamate receptors and VDCCs, did not induce much damage to neurons. However, when 30 PM zinc was added, cell injury was dramatically increased (Fig. 7A) . This damage was inhibited by Gd 3+ , suggesting the involvement of TRPM7 channels. Further supporting this claim, TRPM7-shRNA/eGFP tranfected cells were resistant to injury by zinc-OGD compared to control/eGFP transfeted cells (Fig. 7B and C) . Thus, TRPM7 is involved -9-in zinc toxicity under ischemic condition.
DISCUSSION
The significance of zinc homeostasis in normal brain function and in brain pathology has been increasingly recognized (8, 9, 12, 40, 41) . The role of zinc in neuronal cell death associated with various neurological disorders, for example, has been studied. In ischemic conditions, it has been reported that extracellular chelation of zinc reduces cell injury (9, 12, 42) . In seizure conditions, zinc acts either as an anticonvulsant or proconvulsant depending on the type of seizures (12, 43, 44) . In addition, the potential involvement of zinc in the pathology of Alzheimer's disease has been documented. For example, it has been shown that the amyloid plaque is highly enriched with chelatable zinc and the expression level of ZnTs is altered in patients of Alzheimer's disease (12, 40, 45, 46) . While both the extra-and intracellular zinc are tightly regulated at low levels under physiological conditions, they change dramatically under pathological conditions (12, 40) . Levels of extracellular zinc at tens of micromolar, for example, have been reported following brain ischemia (12, 36, 37) . The increased level of extracellular zinc is accompanied by a dramatic increase in intracellular zinc and resultant neurotoxicity, though the exact zinc entry pathways have not been clearly delineated.
Recent studies have demonstrated that some ion channels and transporters, e.g. VDCCs and glutamate receptor-gated channels, are zinc permeable (16, 17) . Activation of these channels is therefore expected to play a role in zinc homeostasis and toxicity. Unfortunately, clinical trials showed little effectiveness of their blockers in protecting the ischemic brain (3). Searching for additional pathways involved in intracellular zinc accumulation and toxicity may help for establishing new and effective neuroprotective strategies. In this study, we provided strong evidence suggesting that TRPM7 is an important player for intracellular zinc accumulation and zinc-induced neurotoxicity. Based on their non-desensitizing nature and potentiation by acidosis (see below), TRPM7 channels likely play an important role in zinc accumulation associated with ischemic neuronal injury.
Studies by Monteilth-Zoller et al. first indicated zinc permeation through recombinant TRPM7 channels, using the electrophysiological measurement (12, 25) . The studies were performed using millimolar concentrations of zinc, which are several orders of magnitude higher than the physiological/pathophysiological concentrations of zinc (12, 25) . In the present studies, we explored the role of native TRPM7 channels in intracellular zinc accumulation at physiological/pathological relevant concentrations (12) , and more importantly, in zinc-induced neuronal injury.
Using (50) (51) (52) . This should facilitate the entry of zinc through zinc-permeable channels, thus promoting the zinc-mediated neuronal injury. During ischemia, a significant drop in brain pH also takes place. A reduced pH is known to inhibit the activity of NMDA receptors and VDCCs (53-55), two major zinc permeable channels (16) . Thus, zinc entry through these channels would be limited. In contrast, acidosis has been shown to potentiate, rather than inhibit, the activation of TRPM7 channels (48) . Based on all these factors, TRPM7 channels may represent an important zinc entry pathway in the ischemic brain. Therefore, targeting these channels could be a novel neuroprotective strategy for stroke patients, particularly following the failure of clinical trials using the glutamate antagonists (3).
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Traynelis, S. F., and Cull-Candy, S. G. Cells were treated with the indicated condition for 1 h in the presence of different concentration of Gd 3+ or 100 PM 2-APB. Cells were then incubated with normal culture media for 23 h, followed by LDH release assay. n = 8-15. Cells were then treated with the indicated concentration of zinc for 1 h, incubated with culture medium for 23 h, followed by measurement of LDH release. n = 9. (B) TRPM7(-) or (+) cells were transfected with the plasmid-based TRPM7-shRNA or mock vector, then either untreated or treated with tetracycline for 2 days. TRPM7 protein levels were examined by immunoblotting using an antibody for TRPM7 (upper). Protein loading was monitored by immunoblotting using an antibody for E-actin (lower). n = 3. (C) TRPM7(-) or (+) cells were transfected with the plasmid-based TRPM7-shRNA or mock vector, then treated with or without zinc as indicated. n = 8. 6 -Luc, a firefly luciferase reporter plasmid containing six tandem repeats of MRE, and pRL-TK, a control renilla luciferase reporter plasmid. 2 h after transfection, TRPM7 expression was uninduced or induced by adding tetracycline. 40 h after transfection, cells were either untreated or treated with 100 PM zinc for 8 h before being harvested. For each condition, the ratio of firefly luciferase activity to renilla luciferase activity was calculated. n = 5. with 100 PM zinc for 8 h before being harvested. For each condition, the ratio of firefly luciferase activity to renilla luciferase activity was calculated. n = 8. Normalized LDH value 
